Celldex Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 39.5%.

Top 25 shareholders own 86.73% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.8%	FMR LLC	9,725,969	US$370.6m	38%	0.02%
11.6%	Wellington Management Group LLP	7,647,457	US$291.4m	18.1%	0.04%
6.85%	BlackRock, Inc.	4,511,924	US$171.9m	22.8%	no data
5.54%	The Vanguard Group, Inc.	3,650,582	US$139.1m	19.8%	no data
4.73%	Eventide Asset Management, LLC	3,119,087	US$118.8m	-14.1%	1.96%
4.68%	T. Rowe Price Group, Inc.	3,087,208	US$117.6m	631%	0.01%
4.64%	Polar Capital Holdings Plc	3,059,492	US$116.6m	-2.44%	0.47%
4.52%	State Street Global Advisors, Inc.	2,979,751	US$113.5m	25.3%	no data
4.4%	Kynam Capital Management, LP	2,900,000	US$110.5m	-3.52%	9.12%
4.24%	Bellevue Asset Management AG	2,796,615	US$106.6m	15.7%	1.21%
2.27%	Pictet Asset Management Limited	1,494,955	US$57.0m	-32.8%	0.04%
2.15%	Geode Capital Management, LLC	1,414,378	US$53.9m	26.5%	no data
2.08%	Rock Springs Capital Management LP	1,372,185	US$52.3m	41.5%	1.41%
2.07%	Point72 Asset Management, L.P.	1,365,020	US$52.0m	-50.5%	0.11%
1.36%	Marshall Wace LLP	898,800	US$34.2m	-29.8%	0.07%
1.36%	Redmile Group, LLC	896,454	US$34.2m	-9.8%	1.32%
1.31%	Commodore Capital LP	866,468	US$33.0m	23.4%	2.38%
1.22%	Sofinnova Investment, Inc.	801,777	US$30.5m	-5%	1.87%
1.14%	Woodline Partners LP	751,060	US$28.6m	93.8%	0.27%
1.08%	Eversept Partners, L.P.	711,115	US$27.1m	-5.7%	1.97%
1.04%	Jennison Associates LLC	688,080	US$26.2m	3,330%	0.02%
0.99%	EcoR1 Capital, LLC	650,000	US$24.8m	0%	0.71%
0.99%	Logos Global Management, L.P.	650,000	US$24.8m	0%	2.9%
0.87%	D. E. Shaw & Co., L.P.	573,171	US$21.8m	2,310%	0.03%
0.84%	Northern Trust Global Investments	553,861	US$21.1m	24.5%	no data